These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1535200)

  • 1. Adjuvant hormone therapy in breast cancer.
    Blomqvist CP; Elomaa I; Rissanen P
    Ann Med; 1992 Apr; 24(2):91-6. PubMed ID: 1535200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.
    Boyages J; Tiver KW
    Aust N Z J Surg; 1992 May; 62(5):354-63. PubMed ID: 1575655
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer.
    Love RR; Duc NB; Allred DC; Binh NC; Dinh NV; Kha NN; Thuan TV; Mohsin SK; Roanh le D; Khang HX; Tran TL; Quy TT; Thuy NV; Thé PN; Cau TT; Tung ND; Huong DT; Quang le M; Hien NN; Thuong L; Shen TZ; Xin Y; Zhang Q; Havighurst TC; Yang YF; Hillner BE; DeMets DL
    J Clin Oncol; 2002 May; 20(10):2559-66. PubMed ID: 12011136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor-Positive Breast Cancer: A Global Treatment Option.
    Love RR
    Clin Breast Cancer; 2016 Aug; 16(4):233-7. PubMed ID: 27117241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian ablation as treatment for young women with breast cancer.
    Davidson NE
    J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Emens LA; Davidson NE
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):486S-94S. PubMed ID: 12538505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1992 Jan; 339(8784):1-15. PubMed ID: 1345950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
    Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
    Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer.
    Nordenskjöld A; Fohlin H; Fornander T; Löfdahl B; Skoog L; Stål O
    Breast Cancer Res Treat; 2016 Nov; 160(2):313-322. PubMed ID: 27722840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.
    Rose C; Thorpe SM; Andersen KW; Pedersen BV; Mouridsen HT; Blichert-Toft M; Rasmussen BB
    Lancet; 1985 Jan; 1(8419):16-9. PubMed ID: 2856949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant endocrine forms of therapy in breast cancer].
    Jakesz R; Hausmaninger H
    Wien Klin Wochenschr; 1984 Jun; 96(13):492-9. PubMed ID: 6475078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current controversies in breast cancer management.
    Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
    Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant endocrine therapy for premenopausal women: Type and duration.
    Francis PA
    Breast; 2017 Aug; 34 Suppl 1():S108-S111. PubMed ID: 28669713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
    Lee ES; Han W; Kim MK; Kim J; Yoo TK; Lee MH; Lee KH; Kim TY; Moon HG; Im SA; Noh DY; Lee ES
    BMC Cancer; 2016 Jul; 16():430. PubMed ID: 27388210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials.
    Ibrahim EM; Al-Hajeili MR; Bayer AM; Abulkhair OA; Refae AA
    Med Oncol; 2017 Jul; 34(7):131. PubMed ID: 28620883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.